Zobrazeno 1 - 10
of 90
pro vyhledávání: '"Y, Pilatte"'
Autor:
Jocelyne Fleury-Feith, I Monnet, F Levy, P Chretien, Y. Pilatte, Claire Vivo, Laurence Kheuang, M C Jaurand
Publikováno v:
Oncogene. 20:1085-1093
Recombinant human interferon gamma (r-hu-IFNgamma) exerts both antitumoral activity in the early stages of human malignant mesothelioma and a cytostatic effect in human mesothelioma (HM) cell lines in vitro. The antiproliferative effect of interferon
Publikováno v:
Xenotransplantation. 7:3-13
The identification of the xeno-antigens/xeno-antibodies combinations involved in pig-to-human xenograft rejection is an essential step for understanding this process and for the development of procedures to prevent it. Although it is widely accepted
Publikováno v:
Clinical and Experimental Immunology. 86:157-162
SUMMARY Immunolherapy of cancers with recombinant IL-2 induces a vascular leak syndrome which is mainly due to an increase in vascular permeability. A lymphokine, the vascular permeability factor (VPF), which increases vascular permeability, has been
Publikováno v:
Xenotransplantation. 7(1)
The identification of the xeno-antigens/xeno-antibodies combinations involved in pig-to-human xenograft rejection is an essential step for understanding this process and for the development of procedures to prevent it. Although it is widely accepted
Shedding of CD44 from PMA-differentiated U-937 cells is enhanced by treatment with mineral particles
Autor:
Laurence Kheuang, Marie Claude Jaurand, Noureddine Trabelsi, Jean Bignon, Anne Greffard, Y. Pilatte, Jean Claude Pairon
Publikováno v:
Biochemical and biophysical research communications. 245(1)
In this report, we show that enhanced shedding of CD44 might contribute to the down-regulation of this receptor observed after phagocytosis of MnO 2 particles by PMA-differentiated U-937. The apparent Mr of the soluble CD44 detected in culture supern
Publikováno v:
Cancer research. 58(4)
Intrapleural injections of recombinant human IFN-gamma have shown some efficacy in reducing tumor growth in early stages of diffuse malignant mesothelioma (DMM). Here, we have addressed the potential therapeutic effect of IFN-gamma in DMM by investig
Autor:
G, Rostoker, D, Desvaux-Belghiti, Y, Pilatte, M, Petit-Phar, C, Philippon, L, Deforges, H, Terzidis, L, Intrator, C, André, S, Adnot
Publikováno v:
Nephron. 69(3)
Recently, our group has shown that a 3-month course of intravenous immunoglobulin (2 g/kg/monthly) followed by 6 months of intramuscular immunoglobulins (IMIG, 16.5%, 0.35 ml/kg every 15 days) was able to slow or to stop the decline in the glomerular
Autor:
A. Greffard, Marie-Claude Jaurand, Y. Pilatte, Jean Bignon, D. Pradel, Annie Buard, Laure Saint-Etienne
Publikováno v:
Lung Cancer. 15:268-269
Publikováno v:
European Journal of Cancer. 37:S41
Publikováno v:
Lung Cancer. 15:262